These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 15836658

  • 1. Prognostic value of erythrocyte sedimentation rate in ST segment elevation myocardial infarction: interaction with hyperglycaemia.
    Timmer JR, Ottervanger JP, Hoorntje JC, De Boer MJ, Suryapranata H, van 't Hof AW, Zijlstra F, Zwolle Myocardial Infarction study group.
    J Intern Med; 2005 May; 257(5):423-9. PubMed ID: 15836658
    [Abstract] [Full Text] [Related]

  • 2. Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention.
    Pres D, Gasior M, Strojek K, Gierlotka M, Hawranek M, Lekston A, Wilczek K, Tajstra M, Gumprecht J, Poloński L.
    Kardiol Pol; 2010 Jul; 68(7):743-51. PubMed ID: 20648428
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction.
    Timmer JR, van der Horst IC, Ottervanger JP, Henriques JP, Hoorntje JC, de Boer MJ, Suryapranata H, Zijlstra F, Zwolle Myocardial Infarction Study Group.
    Am Heart J; 2004 Sep; 148(3):399-404. PubMed ID: 15389225
    [Abstract] [Full Text] [Related]

  • 4. Relationship between blood glucose on admission and prognosis in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Gasior M, Stasik-Pres G, Pres D, Lech P, Gierlotka M, Lekston A, Hawranek M, Tajstra M, Kalarus Z, Poloński L.
    Kardiol Pol; 2007 Sep; 65(9):1031-8; discussion 1039-40. PubMed ID: 17975750
    [Abstract] [Full Text] [Related]

  • 5. [Effect of admission blood glucose levels on the short term mortality in patients with acute ST-segment elevation myocardial infarction].
    Yang YM, Liu Y, Zhu J, Tan HQ, Liang Y, Li Y, Li JD, Zhang Y, Liu LS.
    Zhonghua Yi Xue Za Zhi; 2009 May 12; 89(18):1230-3. PubMed ID: 19595174
    [Abstract] [Full Text] [Related]

  • 6. Treatment of acute ST-segment elevation myocardial infarction in West Pomerania province of Poland. Comparison between primary coronary intervention and thrombolytic therapy.
    Dryja T, Kornacewicz-Jach Z, Goracy J, Przybycień K, Jodko L, Skowronek A, Kurowski M, Zinka E.
    Kardiol Pol; 2006 Jun 12; 64(6):591-9; discussion 600-1. PubMed ID: 16810577
    [Abstract] [Full Text] [Related]

  • 7. The significance of circulating levels of both cardiac troponin I and high-sensitivity C reactive protein for the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarction.
    Foussas SG, Zairis MN, Makrygiannis SS, Manousakis SJ, Anastassiadis FA, Apostolatos CS, Patsourakos NG, Glyptis MP, Papadopoulos JK, Xenos DC, Adamopoulou EN, Olympios CD, Argyrakis SK.
    Heart; 2007 Aug 12; 93(8):952-6. PubMed ID: 17344331
    [Abstract] [Full Text] [Related]

  • 8. Does glucose level at hospital discharge predict one-year mortality in patients with diabetes mellitus treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction?
    Gasior M, Pres D, Stasik-Pres G, Lech P, Gierlotka M, Lekston A, Hawranek M, Tajstra M, Kalarus Z, Poloński L.
    Kardiol Pol; 2008 Jan 12; 66(1):1-8; discussion 9-11. PubMed ID: 18266182
    [Abstract] [Full Text] [Related]

  • 9. Long-term, cause-specific mortality after myocardial infarction in diabetes.
    Timmer JR, Ottervanger JP, Thomas K, Hoorntje JC, de Boer MJ, Suryapranata H, Zijlstra F, Zwolle Myocardial Infarction Study Group.
    Eur Heart J; 2004 Jun 12; 25(11):926-31. PubMed ID: 15172464
    [Abstract] [Full Text] [Related]

  • 10. [Prognostic value of white blood cell count in acute myocardial infarction: long-term mortality].
    Núñez J, Fácila L, Llàcer A, Sanchís J, Bodí V, Bertomeu V, Sanjuán R, Blasco ML, Consuegra L, Bosch MJ, Chorro FJ.
    Rev Esp Cardiol; 2005 Jun 12; 58(6):631-9. PubMed ID: 15970118
    [Abstract] [Full Text] [Related]

  • 11. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes.
    Vis MM, Sjauw KD, van der Schaaf RJ, Baan J, Koch KT, DeVries JH, Tijssen JG, de Winter RJ, Piek JJ, Henriques JP.
    Am Heart J; 2007 Dec 12; 154(6):1184-90. PubMed ID: 18035093
    [Abstract] [Full Text] [Related]

  • 12. Acute hyperglycaemia and inflammation in patients with ST segment elevation myocardial infarction.
    Terlecki M, Bednarek A, Kawecka-Jaszcz K, Czarnecka D, Bryniarski L.
    Kardiol Pol; 2013 Dec 12; 71(3):260-7. PubMed ID: 23575781
    [Abstract] [Full Text] [Related]

  • 13. Comparison of prognostic value of epicardial blood flow and early ST-segment resolution after primary coronary angioplasty. ANIN--Myocardial Infarction Registry.
    Kalińczuk Ł, Przyłuski J, Karcz M, Petryka J, Kaczmarska E, Bekta P, Kepka C, Kruk M, Pregowski J, Kadziela J, Deptuch T, Skwarek M, Cedro K, Ciszewski M, Debski A, Ciszewski A, Chmielak Z, Demkow M, Witkowski A, Ruzyłło W.
    Kardiol Pol; 2007 Jan 12; 65(1):1-10; discussion 11-2. PubMed ID: 17295155
    [Abstract] [Full Text] [Related]

  • 14. Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes.
    Foussas SG, Zairis MN, Lyras AG, Patsourakos NG, Tsirimpis VG, Katsaros K, Beldekos DJ, Handanis SM, Mytas DZ, Karidis KS, Tselioti PG, Prekates AA, Ambrose JA.
    Am J Cardiol; 2005 Aug 15; 96(4):533-7. PubMed ID: 16098307
    [Abstract] [Full Text] [Related]

  • 15. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
    Gibson CM, Murphy SA, Pride YB, Kirtane AJ, Aroesty JM, Stein EB, Ciaglo LN, Southard MC, Sabatine MS, Cannon CP, Braunwald E, TIMI Study Group.
    Am Heart J; 2008 Jan 15; 155(1):133-9. PubMed ID: 18082504
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
    Idorn L, Høfsten DE, Wachtell K, Mølgaard H, Egstrup K, DANAMI-2 Investigators.
    Am J Cardiol; 2007 Sep 15; 100(6):937-43. PubMed ID: 17826373
    [Abstract] [Full Text] [Related]

  • 17. What level of hyperglycaemia on admission indicates a poor prognosis in patients with myocardial infarction treated invasively?
    Tomaszuk Kazberuk A, Kożuch M, Małyszko J, Bachórzewska Gajewska H, Dobrzycki S, Kosacka U, Musiał WJ.
    Kardiol Pol; 2012 Sep 15; 70(6):564-72. PubMed ID: 22718372
    [Abstract] [Full Text] [Related]

  • 18. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Gibson CM, Pride YB, Buros JL, Lord E, Shui A, Murphy SA, Pinto DS, Zimetbaum PJ, Sabatine MS, Cannon CP, Josephson ME, TIMI Study Group.
    J Am Coll Cardiol; 2008 Feb 05; 51(5):546-51. PubMed ID: 18237683
    [Abstract] [Full Text] [Related]

  • 19. Thrombolysis followed by early revascularization: an effective reperfusion strategy in real world patients with ST-elevation myocardial infarction.
    Jaffe R, Halon DA, Karkabi B, Goldstein J, Rubinshtein R, Flugelman MY, Lewis BS.
    Cardiology; 2007 Feb 05; 107(4):329-36. PubMed ID: 17268198
    [Abstract] [Full Text] [Related]

  • 20. TIMI Risk Score accurately predicts risk of death in 30-day and one-year follow-up in STEMI patients treated with primary percutaneous coronary interventions.
    Kozieradzka A, Kamiński K, Dobrzycki S, Nowak K, Musiał W.
    Kardiol Pol; 2007 Jul 05; 65(7):788-95; discussion 796-7. PubMed ID: 17694460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.